Therapeutic angiogenesis using autologous adipose-derived regenerative cells in patients with critical limb ischaemia in Japan: a clinical pilot study
Autor: | Kazumasa Unno, Yuuki Shimizu, Yuzuru Kamei, Ryo Hayashida, Ryosuke Kikuchi, Kimihiro Komori, Keisuke Takanari, Satoshi Shintani, Takeshi Katagiri, Kazuhisa Kondo, Akio Kodama, Rei Shibata, Toyoaki Murohara, Shukuro Yamaguchi |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Adult Male medicine.medical_specialty Angiogenesis Urology Adipose tissue Neovascularization Physiologic lcsh:Medicine Pilot Projects 030204 cardiovascular system & hematology Mesenchymal Stem Cell Transplantation Transplantation Autologous Article Neovascularization 03 medical and health sciences Peripheral Arterial Disease 0302 clinical medicine Japan Ischemia Adipocytes Medicine Humans Regeneration Therapeutic angiogenesis Progenitor cell lcsh:Science Aged Adult stem cells Multidisciplinary business.industry lcsh:R Adipose-Derived Regenerative Cells Thromboangiitis Obliterans Mesenchymal Stem Cells Middle Aged Transplantation 030104 developmental biology Cardiovascular diseases Adipose Tissue Peripheral vascular disease Angiogenesis Inducing Agents Female lcsh:Q medicine.symptom business Adult stem cell Stem Cell Transplantation |
Zdroj: | Scientific Reports, Vol 10, Iss 1, Pp 1-12 (2020) Scientific Reports |
ISSN: | 2045-2322 |
DOI: | 10.1038/s41598-020-73096-y |
Popis: | Adipose-derived regenerative cell (ADRC) is a promising alternative source of autologous somatic stem cells for the repair of damaged tissue. This study aimed to assess the safety and feasibility of autologous ADRC implantation for therapeutic angiogenesis in patients with critical limb ischaemia (CLI). A clinical pilot study—Therapeutic Angiogenesis by Cell Transplantation using ADRCs (TACT-ADRC) study—was initiated in Japan. Adipose tissue was obtained by ordinary liposuction method. Isolated ADRCs were injected into the ischaemic limb. We performed TACT-ADRC procedure in five patients with CLI. At 6 months, no adverse events related to the TACT-ADRC were observed. No patients required major limb amputation, and ischaemic ulcers were partly or completely healed during the 6-month follow-up. In all cases, significant clinical improvements were seen in terms of rest pain and 6-min walking distance. Numbers of circulating CD34+ and CD133+ cells markers of progenitor cell persistently increased after ADRC implantation. The ratio of VEGF-A165b (an anti-angiogenic isoform of VEGF) to total VEGF-A in plasma significantly decreased after ADRC implantation. In vitro experiments, cultured with ADRC-conditioned media (CM) resulted in increased total VEGF-A and decreased VEGF-A165b in C2C12 cells, but not in macrophages. ADRC-CM also increased CD206+ cells expression and decreased TNF-α in macrophages. Autologous ADRC implantation was safe and effective in patients with CLI and could repair damaged tissue via its ability to promote angiogenesis and suppress tissue inflammation. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |